Strut Anti-Aging Formula review: separate the facial cream from eye and neck copy

The facial description names tretinoin, niacinamide and lactic acid with sodium hyaluronate in a prescription dermatology cream. The repeated price displays say $49 for 15 grams and mention auto-refill. The later facial ingredient FAQ repeats that four-ingredient identity. These are the clearest preparation facts for the offer being reviewed. Strut product page

The repeated headings also carry eye- and neck-area language, so repetition alone does not make every surrounding sentence part of one consistent formula. The options comparison keeps the named offers separate. A current facial prescription would still need to establish its selected strengths and correspondence with the pharmacy’s preparation record. Strut product page

The safety section places the four ingredients in Prescription Dermatology Base Cream. Another facial FAQ describes a hypoallergenic dermatological base. That gives the advertised preparation a dosage form and a brand-attributed characteristic, but it does not name every inactive component or provide a complete base declaration in the reviewed passages. Strut product page

Hypoallergenic should not become a guarantee about an individual’s response. The full formulation would matter to a concrete ingredient question, and FDA describes pharmacists as a resource for interpreting medication information. The vehicle guide explains why an active roster and a base description answer different parts of the prescription question. Strut product page FDA pharmacist guidance

One section describes an eye cream with seven ingredients, including tacrolimus, vitamin C, caffeine and chamomile extract. Another describes a six-ingredient neck formula with caffeine and DMAE. Those modules differ from the facial four-ingredient declaration. Their percentages and ingredient explanations cannot be inserted into the facial product as if they were missing specifications. Strut product page

The reviewed page does not resolve this mixture of product material. Preserving the distinction is more accurate than combining every list into one stronger-sounding cream. The Hims preparation review provides a separate cream record to examine; its formula also cannot supply missing information for Strut’s facial prescription. Strut product page

The product FAQ describes remote evaluation by US-licensed physicians and a custom preparation from a pharmacy. The terms give the organizational distinction more precisely: Titan Medical Group delivers clinical services through Strut’s platform, and the providers are responsible for the care. Strut describes itself as facilitating communication rather than providing medical care. Strut product page Strut terms

The prescription-policy section also says a prescription is not guaranteed and recognizes pharmacy choice. These are public descriptions of responsibilities, not proof of an observed consultation, pharmacy accreditation or dispensing event. The dispensing-record article explains how the actual prescriber and pharmacy information can connect the offer to a particular preparation. Strut terms

The facial FAQ says the online visit is typically complimentary and that a person who does not qualify will not be charged. It separately lists a $40 physician consultation charge for transfer to a nonpreferred pharmacy. The advertised $49 for 15 grams is a medication offer, rather than a universal complete charge for every possible arrangement. Strut product page

The terms state that prescriptions are subscriptions charged every 30 or 90 days, depending on refill schedule, until paused or cancelled. Those general intervals do not identify one reader’s selected schedule or the dating of a container. The Dermatica cream review offers another route into separating package descriptions from a commercial delivery period. Strut terms

Strut calls its preparation individualized and describes a compound as mixed for the patient using the doctor’s requested strengths, ingredients and dosage form. The product also states that compounds are not FDA-approved and have not been evaluated by FDA for safety, effectiveness or quality. These disclosures belong with its ingredient-driven benefits. Strut product page

The word synergistic in the facial FAQ is not a controlled finished-formula comparison supplied by these records. FDA’s compounding explanation preserves the distinction between a compound and an approved medicine. The combination-ingredient guide addresses that evidence question without treating four ingredients as four measured advantages or predicting personal comfort. Strut product page FDA compounding explanation

Strut includes a storage FAQ beside the facial ingredient questions. Its existence is useful context, but this review does not convert it into directions for a reader’s medicine. The mixed page also leaves the full facial base and individual package record open. No container, fill date or delivery history was examined here. Strut product page

FDA’s stability explanation connects dating with a product and its labeled conditions. The container article keeps that information attached to the supplied preparation. For Strut, the reliable public starting point is the four-ingredient facial declaration and 15 g offer, with a separate pharmacy record needed to make the actual prescription more specific. FDA stability explanation Strut product page